227 related articles for article (PubMed ID: 25162437)
1. Light and Dark of Reactive Oxygen Species for Vascular Function: 2014 ASVB (Asian Society of Vascular Biology).
Shimokawa H; Satoh K
J Cardiovasc Pharmacol; 2015 May; 65(5):412-8. PubMed ID: 25162437
[TBL] [Abstract][Full Text] [Related]
2. Rho-kinase: important new therapeutic target in cardiovascular diseases.
Satoh K; Fukumoto Y; Shimokawa H
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H287-96. PubMed ID: 21622831
[TBL] [Abstract][Full Text] [Related]
3. RhoA/Rho-Kinase in the Cardiovascular System.
Shimokawa H; Sunamura S; Satoh K
Circ Res; 2016 Jan; 118(2):352-66. PubMed ID: 26838319
[TBL] [Abstract][Full Text] [Related]
4. Dual roles of vascular-derived reactive oxygen species--with a special reference to hydrogen peroxide and cyclophilin A.
Satoh K; Godo S; Saito H; Enkhjargal B; Shimokawa H
J Mol Cell Cardiol; 2014 Aug; 73():50-6. PubMed ID: 24406688
[TBL] [Abstract][Full Text] [Related]
5. Cyclophilin A in cardiovascular homeostasis and diseases.
Satoh K
Tohoku J Exp Med; 2015 Jan; 235(1):1-15. PubMed ID: 25743766
[TBL] [Abstract][Full Text] [Related]
6. 2015 ATVB Plenary Lecture: translational research on rho-kinase in cardiovascular medicine.
Shimokawa H; Satoh K
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1756-69. PubMed ID: 26069233
[TBL] [Abstract][Full Text] [Related]
7. Rho-kinase is an important therapeutic target in cardiovascular medicine.
Shimokawa H; Takeshita A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
[TBL] [Abstract][Full Text] [Related]
8. Development of Rho-kinase inhibitors for cardiovascular medicine.
Shimokawa H; Rashid M
Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681
[TBL] [Abstract][Full Text] [Related]
9. Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cells.
Byon CH; Heath JM; Chen Y
Redox Biol; 2016 Oct; 9():244-253. PubMed ID: 27591403
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?
Touyz RM
Hypertension; 2004 Sep; 44(3):248-52. PubMed ID: 15262903
[TBL] [Abstract][Full Text] [Related]
11. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
Budzyn K; Marley PD; Sobey CG
Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
[TBL] [Abstract][Full Text] [Related]
12. Vascular-derived reactive oxygen species for homeostasis and diseases.
Satoh K; Berk BC; Shimokawa H
Nitric Oxide; 2011 Aug; 25(2):211-5. PubMed ID: 21565278
[TBL] [Abstract][Full Text] [Related]
13. Redox regulation of protein kinases as a modulator of vascular function.
Knock GA; Ward JP
Antioxid Redox Signal; 2011 Sep; 15(6):1531-47. PubMed ID: 20849377
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease.
Haybar H; Shahrabi S; Rezaeeyan H; Shirzad R; Saki N
Cardiovasc Toxicol; 2019 Feb; 19(1):13-22. PubMed ID: 30506414
[TBL] [Abstract][Full Text] [Related]
15. Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats.
Sari AN; Kacan M; Unsal D; Sahan Firat S; Kemal Buharalioglu C; Vezir O; Korkmaz B; Cuez T; Canacankatan N; Sucu N; Ayaz L; Tamer Gumus L; Gorur A; Tunctan B
Eur J Pharmacol; 2014 Jan; 723():234-45. PubMed ID: 24296316
[TBL] [Abstract][Full Text] [Related]
16. [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling].
Jalil J; Lavandero S; Chiong M; Ocaranza MP
Rev Esp Cardiol; 2005 Aug; 58(8):951-61. PubMed ID: 16053829
[TBL] [Abstract][Full Text] [Related]
17. Recent evidence for an involvement of rho-kinase in cerebral vascular disease.
Chrissobolis S; Sobey CG
Stroke; 2006 Aug; 37(8):2174-80. PubMed ID: 16809566
[TBL] [Abstract][Full Text] [Related]
18. Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
Shi J; Wei L
J Cardiovasc Pharmacol; 2013 Oct; 62(4):341-54. PubMed ID: 23921309
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology.
Touyz RM
Antioxid Redox Signal; 2005; 7(9-10):1302-14. PubMed ID: 16115036
[TBL] [Abstract][Full Text] [Related]
20. The role of the RhoA/rho-kinase pathway in pulmonary hypertension.
Nossaman BD; Kadowitz PJ
Curr Drug Discov Technol; 2009 Mar; 6(1):59-71. PubMed ID: 19275543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
